Literature DB >> 3494392

Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency.

R A Bouillon, J H Auwerx, W D Lissens, W K Pelemans.   

Abstract

The seasonal variation of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol was analyzed in 240 elderly subjects (mean age: 78 yr) in Belgium. Serum 25-hydroxycholecalciferol was lowest from February until May (mean levels less than 25 nmol/L). Summer peak levels were, however, not higher than nadir levels in younger control subjects. A seasonal variation in total and free 1,25-dihydroxycholecalciferol concentrations was also observed in the geriatric population with a nadir in February and March (50 +/- 24 pmol/L). The peak values in summer (110 +/- 33 pmol/L) were not different from those of the younger controls. Serum calcium and phosphate were decreased whereas alkaline phosphatase and parathyroid hormone were increased throughout the year in the geriatric patients. Oral 25-hydroxycholecalciferol treatment rapidly normalized serum 1,25-dihydroxycholecalciferol concentrations in vitamin D-deficient subjects. Deficiency of both the vitamin D substrate and hormone is frequent in the elderly population in Belgium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494392     DOI: 10.1093/ajcn/45.4.755

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  40 in total

1.  Effects of physical activity and dietary calcium intake on bone mineral density and osteoporosis risk in a rural Thai population.

Authors:  C Pongchaiyakul; T V Nguyen; V Kosulwat; N Rojroongwasinkul; S Charoenkiatkul; J A Eisman; R Rajatanavin
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

2.  Vitamin D insufficiency, deficiency, and bone health.

Authors:  J Chris Gallagher; Adarsh J Sai
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

3.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

4.  Seasonal differences in biochemical parameters of bone remodelling.

Authors:  A S Douglas; M H Miller; D M Reid; J D Hutchison; R W Porter; S P Robins
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

5.  Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease.

Authors:  Pankaj Hari; Nandita Gupta; Smriti Hari; Ashima Gulati; Puneet Mahajan; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2010-09-25       Impact factor: 3.714

Review 6.  The pathogenesis and treatment of hip fractures.

Authors:  P Lips; K J Obrant
Journal:  Osteoporos Int       Date:  1991-09       Impact factor: 4.507

7.  Severe vitamin D deficiency in the institutionalized elderly.

Authors:  P D Papapetrou; M Triantafyllopoulou; A Korakovouni
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

Review 8.  Vitamin D and bone health: Epidemiologic studies.

Authors:  Peter R Ebeling
Journal:  Bonekey Rep       Date:  2014-03-05

9.  Calciotropic hormones in elderly people with and without hip fracture.

Authors:  C L Benhamou; D Tourliere; J B Gauvain; G Picaper; M Audran; P Jallet
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

10.  Determinants of serum calcium in men and women. The Tromsø Study.

Authors:  R Jorde; J Sundsfjord; K H Bønaa
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.